Overview
- 14 inspections across 14 sites are on record.
- 61 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-01.
At a glance
Inspections
14
Sites
14
Observations
61
Career since
Jan 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| GVS TM, Inc | 1 May 2026 | Biologics | View 483 → |
| Pacira Pharmaceuticals, Inc. | 25 Mar 2026 | Human Drugs | On file |
| Element Materials Technology Oakland-Concord | 30 Jan 2026 | Human Drugs | View 483 → |
| B. Braun US Pharmaceutical Manufacturing, LLC | 21 Nov 2025 | Human Drugs | View 483 → |
| Central Admixture Pharmacy Services, Inc. | 5 Sep 2025 | Human Drugs | View 483 → |
Sites inspected
GVS TM, IncCovina, United States1 insp.
Pacira Pharmaceuticals, Inc.San Diego, United States1 insp.
Element Materials Technology Oakland-ConcordConcord, United States1 insp.
B. Braun US Pharmaceutical Manufacturing, LLCIrvine, United States1 insp.
Central Admixture Pharmacy Services, Inc.Phoenix, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Roger F Zabinski3 shared
Joey V Quitania2 shared
Lillian S Wu2 shared
Walden H Lee2 shared
Michael T Cyrus2 shared
Joanne E King2 shared
Veronica Fuentes2 shared
John A Liu2 shared
Alexandra A Cole1 shared
Gloria E Andia1 shared
Full investigator report
Get the verbatim findings behind Homero W Aguilar's 61 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site